These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7863014)

  • 61. Differential effects of cholecystokinin (CCK-8) microinjection into the ventrolateral and dorsolateral periaqueductal gray on anxiety models in Wistar rats.
    Vázquez-León P; Campos-Rodríguez C; Gonzalez-Pliego C; Miranda-Páez A
    Horm Behav; 2018 Nov; 106():105-111. PubMed ID: 30342011
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Paracrine stimulation of cell growth by cholecystokinin/gastrin through cholecystokinin-B receptor on GH3 cells in vitro.
    Xu Y; Kaji H; Okimura Y; Matsui T; Abe H; Chihara K
    Neuroendocrinology; 1996 Oct; 64(4):280-5. PubMed ID: 8895857
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Electrophysiological evidence for the presence of receptors for cholecystokinin and bombesin on cultured astrocytes of rat central nervous system.
    Hösli L; Hösli E; Winter T; Käser H
    Neurosci Lett; 1993 Dec; 163(2):145-7. PubMed ID: 8309621
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evidence that CCKB receptors mediate the regulation of exploratory behaviour in the rat.
    Harro J; Vasar E
    Eur J Pharmacol; 1991 Feb; 193(3):379-81. PubMed ID: 2055248
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Receptors for cholecystokinin and gastrin].
    de Weerth A; Bläker M; von Schrenck T
    Z Gastroenterol; 1999 May; 37(5):389-401. PubMed ID: 10413847
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Brain CCK-B receptors mediate the suppression of dopamine release by cholecystokinin.
    Altar CA; Boyar WC
    Brain Res; 1989 Apr; 483(2):321-6. PubMed ID: 2706523
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Activation of neural cholecystokinin-1 receptors induces relaxation of the isolated rat duodenum which is reduced by nitric oxide synthase inhibitors.
    Martins SR; Oliveira RB; Ballejo G
    Braz J Med Biol Res; 2006 Feb; 39(2):271-5. PubMed ID: 16470315
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Peripheral gene expression profiling of CCK-4-induced panic in healthy subjects.
    Maron E; Kallassalu K; Tammiste A; Kolde R; Vilo J; Tõru I; Vasar V; Shlik J; Metspalu A
    Am J Med Genet B Neuropsychiatr Genet; 2010 Jan; 153B(1):269-74. PubMed ID: 19051287
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Gene variations in the cholecystokinin system in patients with panic disorder.
    Koefoed P; Woldbye DP; Hansen TO; Hansen ES; Knudsen GM; Bolwig TG; Rehfeld JF
    Psychiatr Genet; 2010 Apr; 20(2):59-64. PubMed ID: 20023595
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of endogenous cholecystokinin and cholecystokinin-A receptors in the development of acute pancreatitis in rats.
    Tachibana I; Shirohara H; Czako L; Akiyama T; Nakano S; Watanabe N; Hirohata Y; Otsuki M
    Pancreas; 1997 Mar; 14(2):113-21. PubMed ID: 9057182
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The CCK-B agonist, BC264, increases dopamine in the nucleus accumbens and facilitates motivation and attention after intraperitoneal injection in rats.
    Ladurelle N; Keller G; Blommaert A; Roques BP; Daugé V
    Eur J Neurosci; 1997 Sep; 9(9):1804-14. PubMed ID: 9383203
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Central nervous system cholecystokinin and the control of feeding behavior in sheep.
    Della-Fera MA; Baile CA
    Prog Clin Biol Res; 1985; 192():115-22. PubMed ID: 3001747
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Experimental panic provocation in healthy man-a translational role in anti-panic drug development?
    Kellner M
    Dialogues Clin Neurosci; 2011; 13(4):485-93. PubMed ID: 22275853
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Overview. Cholecystokinin and eating.
    Beglinger C
    Curr Opin Investig Drugs; 2002 Apr; 3(4):587-8. PubMed ID: 12090729
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models.
    Rotzinger S; Vaccarino FJ
    J Psychiatry Neurosci; 2003 May; 28(3):171-81. PubMed ID: 12790157
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Stimulation of delta-opioid receptors reduces the in vivo binding of the cholecystokinin (CCK)-B-selective agonist [3H]pBC 264: evidence for a physiological regulation of CCKergic systems by endogenous enkephalins.
    Ruiz-Gayo M; Durieux C; Fournié-Zaluski MC; Roques BP
    J Neurochem; 1992 Nov; 59(5):1805-11. PubMed ID: 1357099
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Potential role of cholecystokinin in the development of acute pancreatitis.
    Beglinger C
    Digestion; 1999; 60 Suppl 1():61-3. PubMed ID: 10026434
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Decreased CCK(B) receptor binding in rat amygdala in animals demonstrating greater anxiety-like behavior.
    Wunderlich GR; Raymond R; DeSousa NJ; Nobrega JN; Vaccarino FJ
    Psychopharmacology (Berl); 2002 Nov; 164(2):193-9. PubMed ID: 12404082
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Blockade of CCK(B) but not CCK(A) receptors before and after the stress of predator exposure prevents lasting increases in anxiety-like behavior: implications for anxiety associated with posttraumatic stress disorder.
    Adamec RE; Shallow T; Budgell J
    Behav Neurosci; 1997 Apr; 111(2):435-49. PubMed ID: 9106682
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors.
    Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH
    Cancer Res; 1993 Sep; 53(17):3925-9. PubMed ID: 8358719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.